Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H, Hirano Y, Koike S, Sasabayashi D, Katayama H, Plitman E, Ohi K, Ueno F, Caravaggio F, Koizumi T, Gerretsen P, Suzuki T, Uchida H, Müller DJ, Mimura M, Remington G, Grace AA, Graff-Guerrero A, Nakajima S.
Wada M, et al. Among authors: ueno f.
Mol Psychiatry. 2022 Jul;27(7):2950-2967. doi: 10.1038/s41380-022-01572-0. Epub 2022 Apr 20.
Mol Psychiatry. 2022.
PMID: 35444257
Review.